EASTON BIOPHARMACEUTICALS: Hydrochloride Arolol Tablets have obtained a drug registration certificate
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration, with the related drug name being: Arolol Hydrochloride Tablets. The main active ingredient of Arolol Hydrochloride Tablets is Arolol Hydrochloride, and the main indications are primary hypertension (mild to moderate), angina pectoris, tachyarrhythmia, and essential tremor
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments